← Eichor
Condition: Interstitial Lung Fibrosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Interstitial Lung Fibrosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
NA · 1 location(s) · MGH Institute of Health Professions · NCT06304207Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT00001456Mechanisms of Familial Pulmonary Fibrosis
Phase N/A · 1 location(s) · Vanderbilt University Medical Center · NCT03437486PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND PO
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06917196The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
Phase N/A · 1 location(s) · University of Virginia · NCT06323876An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Phase 2 · 54 location(s) · Avalyn Pharma Inc. · NCT06951217AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
Phase 2 · 3 location(s) · Avalyn Pharma Inc. · NCT07194382Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
Phase N/A · 1 location(s) · University of Pittsburgh · NCT00258570Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis
Phase 2 · 1 location(s) · University of Wisconsin, Madison · NCT06940427H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
Phase 2 · 1 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT06325696Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
EARLY_Phase 1 · 1 location(s) · University of Virginia · NCT06853145Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Phase 3 · 1 location(s) · Argyrios Tzouvelekis · NCT07299695Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
Phase 1 · 1 location(s) · University of Alabama at Birmingham · NCT04362644A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Phase 2 · 1 location(s) · Chiesi Farmaceutici S.p.A. · NCT07516951Explanted Lung Tissues With Pulmonary Fibrosis
Phase N/A · 1 location(s) · University of Chicago · NCT00515567A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
Phase 2 · 46 location(s) · Boehringer Ingelheim · NCT07036523Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases
NA · 1 location(s) · Oslo University Hospital · NCT06732674An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology
Phase N/A · 2 location(s) · Erasmus Medical Center · NCT04304898The Genetics of Pulmonary Fibrosis
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT03478553A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Pro
Phase 2 · 1 location(s) · Sunshine Lake Pharma Co., Ltd. · NCT05139719P4O2 ILD Extension
Phase N/A · 1 location(s) · Amsterdam UMC, location VUmc · NCT06644144Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis
Phase 2 · 1 location(s) · Mannkind Corporation · NCT07679893ILD-SARDs Registry and Biorepository
Phase N/A · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT05007340A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic
Phase 3 · 1 location(s) · Beijing Tide Pharmaceutical Co., Ltd · NCT07464912Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
Phase 1/Phase 2 · 2 location(s) · Paul Szabolcs · NCT03500731Rehabilitation Counselling for Patients with Interstitial Lung Disease
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06815185A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
Phase N/A · 1 location(s) · Qianfoshan Hospital · NCT05895409Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients
Phase N/A · 1 location(s) · Northwestern University · NCT01531257Controls for Respiratory Diseases
Phase N/A · 1 location(s) · Seoul National University Hospital · NCT03120481Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
Phase N/A · 1 location(s) · University of Pittsburgh · NCT00373841
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.